Risk of diabetes mellitus among users of immune checkpoint inhibitors: A population‐based cohort study

BACKGROUND: Immune checkpoint inhibitors (ICIs) are increasingly established cancer therapeutics, but they are associated with new‐onset diabetes mellitus (DM). Such risks have not been adequately quantified, and between‐class and ‐sex differences remain unexplored. METHODS: This was a prospective c...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Jeffrey Shi Kai, Lee, Sharen, Kong, Dicken, Lakhani, Ishan, Ng, Kenrick, Dee, Edward Christopher, Tang, Pias, Lee, Yan Hiu Athena, Satti, Danish Iltaf, Wong, Wing Tak, Liu, Tong, Tse, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134274/
https://www.ncbi.nlm.nih.gov/pubmed/36647331
http://dx.doi.org/10.1002/cam4.5616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134274/
https://www.ncbi.nlm.nih.gov/pubmed/36647331
http://dx.doi.org/10.1002/cam4.5616

Ejemplares similares